Antenatal depression Mental and Behavioural Disorders
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women who are pregnant 2. Mild or moderate depression with or without co-morbid anxiety 3, Both primiparous and multiparous women 4. Between 10 and 20 weeks of pregnancy 5. Edinburgh Depression Scale (EPDS) score above 10 6. Mild or moderate depression according to Clinical Interview Schedule Revised (CIS-R) (Lewis et al 1992) 7. Whether or not they are taking an antidepressant
Exclusion criteria
Exclusion criteria: 1. Psychotic illness 2. Organic brain disorder 3. Bipolar disorder 4. Personality disorder 5. Alcohol or substance dependency 6. Those with high suicide risk judged to be in need of a more intensive intervention 7. If any women miscarry or have a termination during the trial will be offered to continue with the treatment but not included in the main analyses
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Recruitment rate, measured using trial documentation after 9 months of recruitment (October 2019) 2. Number of women who receive complete IPC treatment as judged by the practitioner from practitioner records at the end of the trial 3. Number of women who complete outcome data, measured 4 months after recruitment for each participant 4. Acceptability of IPC and trial design assessed using in-depth interviews at 4-6 months after recruitment 5. Supervisor’s rating of practitioner’s adherence to the IPC model at the end of the trial | — |
Secondary
| Measure | Time frame |
|---|---|
| Measured at baseline and 12 weeks after recruitment for each participant using validated tools completed on paper or online: 1. Depression symptoms are measured using Edinburgh Depression Scale (EPDS) 2. Partner satisfaction and relationships are measured using Revised Dyadic Adjustment Scales (RDAS) 3. Maternal attachment to her unborn baby is measured using Maternal Antenatal Attachment Scale (MAAS) 4. Health-based wellbeing is measured using EQ-5D-5L 5. Wellbeing, particularly for mental health problems, is measured using ReQol-10 | — |
Countries
England, United Kingdom
Contacts
;